Disorder Of O Xylosyl N Acetylgalactosaminylglycan Synthesis C5681048
A rare genetic disorder affecting how sugars attach to certain proteins. It typically appears in infancy with developmental delay, neurological problems, and physical abnormalities. Treatment focuses on managing symptoms and supportive care.
Key facts at a glance
- ICD-10
- E88.9
- ICD-11
- 5A00.0
- Body system
- metabolic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Cobblestone lissencephaly
(neurological)Fatigue or weight changes
(metabolic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Muscle weakness
(musculoskeletal)Platelet dysfunction
(hematologic)Recurrent infections
(immunologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Drug therapy and clinical monitoring
Active treatment with regular monitoring by a healthcare provider is recommended.
Serial neurological and developmental assessment
Ongoing evaluation of neurological function, developmental milestones, and cognitive status with appropriate referrals to specialists when new concerns arise in O-xylosyl-N-acetylgalactosaminylglycan synthesis disorders.
Gross motor skill development program
Therapeutic exercises and activities targeting balance, coordination, and strength to maximize mobility potential and prevent secondary complications from immobility.
Additional treatment options
Muscle tone management
Pharmacological agents such as muscle relaxants or antispasticity medications may be considered for management of hypertonia or dystonia when significantly impacting function.
medicationOrthopedic intervention for skeletal deformities
Surgical correction of severe joint contractures, scoliosis, or limb abnormalities after comprehensive orthopedic evaluation and when conservative management is insufficient.
surgicalIntegrative supportive therapies
Adjunctive therapies such as massage, hydrotherapy, or acupuncture may provide symptomatic relief and improve comfort as part of a comprehensive management approach.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Disorder Of O Xylosyl N Acetylgalactosaminylglycan Synthesis C5681048?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Disorder Of O Xylosyl N Acetylgalactosaminylglycan Synthesis C5681048. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy